Sinovac Biotech Co., Ltd.

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

Phase 3

Completed

Conditions: Poliomyelitis

Interventions: Biological: Experimental vaccine
Biological: IPV control vaccine
Biological: single-person sIPV control vaccine

First Posted Date: 2022-05-23

Last Posted Date: 2024-04-15

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 1572

Registration Number: NCT05386810

Locations: 🇨🇳
Xiangfu District Center for Disease Prevention and Control, Kaifeng, Henan, China
🇨🇳
Xiangcheng County Center for Disease Control and Prevention, Xuchang, Henan, China

A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Phase 3

Completed

Conditions: Seasonal Influenza

Interventions: Biological: Trivalent influenza vaccine(BY)
Biological: Quadrivalent influenza vaccine(0.25ml)
Biological: Quadrivalent influenza vaccine(0.5ml)
Biological: Trivalent influenza vaccine(BV)

First Posted Date: 2022-02-18

Last Posted Date: 2024-05-28

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 217

Registration Number: NCT05245552

Locations: 🇨🇳
Donghai District Center for Disease Prevention and Control, Lianyungang, Jiangsu, China
🇨🇳
Ganyu District Center for Disease Control and Prevention, Lianyungang, Jiangsu, China
🇨🇳
Binhai District Center for Disease Control and Prevention, Yancheng, Jiangsu, China

and more 1 locations

Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shanghai

Conditions: Hand, Foot and Mouth Disease

Interventions: Biological: EV71 Inactivated Vaccine

First Posted Date: 2021-12-21

Last Posted Date: 2022-07-11

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 12500

Registration Number: NCT05166044

Locations: 🇨🇳
Minhang District Center for Disease Control and Prevention, Minhang, Shanghai, China
🇨🇳
Baoshan District Center for Disease Control and Prevention, Baoshan, Shanghai, China
🇨🇳
Jing'an District Center for Disease Control and Prevention, Jing'an, Shanghai, China

and more 3 locations

Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

Phase 4

Completed

Conditions: COVID-19

Interventions: Biological: Experimental Group

First Posted Date: 2021-11-04

Last Posted Date: 2022-08-11

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 520

Registration Number: NCT05107557

Locations: 🇨🇳
Zhanjiang Center for Diseases Control and Prevention, Zhenjiang, Guangdong, China
🇨🇳
Yangchun City Center for Disease Control and Prevention, Yangchun, Guangdong, China

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

Phase 4

Conditions: COVID-19

Interventions: Biological: High-dosage SARS-CoV-2 vaccine
Biological: Medium-dosage SARS-CoV-2 vaccine

First Posted Date: 2021-10-15

Last Posted Date: 2022-03-02

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 1200

Registration Number: NCT05079217

Locations: 🇨🇳
Xinqi City Center for Disease Control and Prevention, Xinqi, Jiangsu, China

A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

Phase 4

Completed

Conditions: Seasonal Influenza

Interventions: Biological: One dose of quadrivalent influenza vaccine
Biological: Two doses of quadrivalent influenza vaccine

First Posted Date: 2021-08-09

Last Posted Date: 2022-08-11

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 600

Registration Number: NCT04997239

Locations: 🇨🇳
Huaiyin Center for Disease Control and Prevention, Huai'an, Jiangsu, China

An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses

Completed

Conditions: Poliomyelitis

Interventions: Biological: Investigational sIPV
Biological: Control IPV

First Posted Date: 2021-08-04

Last Posted Date: 2023-01-12

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 450

Registration Number: NCT04989231

Locations: 🇨🇳
Pizhou county Center for Disease Control and Prevention, Pizhou, Jiangsu, China

A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine

Phase 4

Completed

Conditions: Pneumococcal Infections

Interventions: Biological: Investigational 23-valent PPV
Biological: Control 23-valent PPV

First Posted Date: 2021-08-04

Last Posted Date: 2022-08-12

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 600

Registration Number: NCT04989465

Locations: 🇨🇳
Kaifeng County Center for Disease Control and Prevention, Kaifeng, Henan, China

Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization

Not Applicable

Completed

Conditions: Poliomyelitis

Interventions: Biological: Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses
Biological: Three doses of control wIPV, vaccinated within one-month interval between doses
Biological: Three doses of high-dosage investigational sIPV, vaccinated within one-month interval between doses
Biological: Three doses of medium-dosage investigational sIPV, vaccinated within one-month interval between doses
Biological: Three doses of control sIPV, vaccinated within one-month interval between doses

First Posted Date: 2020-11-06

Last Posted Date: 2020-11-06

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 250

Registration Number: NCT04618783

Locations: 🇨🇳
Pizhou Center for Disease Control and Prevention, Pizhou, Jiangsu, China

Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine

Phase 3

Completed

Conditions: Poliomyelitis

Interventions: Biological: Three doses of experimental sIPV of lot 2 at the schedule of 2,3,4 months of age
Biological: Three doses control wIPV at the schedule of 2,3,4 months of age
Biological: Three doses of experimental sIPV of lot 3 at the schedule of 2,3,4 months of age
Biological: Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age

First Posted Date: 2020-05-13

Last Posted Date: 2021-08-18

Lead Sponsor: Sinovac Biotech Co., Ltd

Target Recruit Count: 1300

Registration Number: NCT04386707

Locations: 🇨🇳
Yanshan County Center for Disease Control and Prevention, Wenshan, Yunnan, China
🇨🇳
Mile City Center for Disease Control and Prevention, Honghe, Yunnan, China
🇨🇳
Gejiu County Center for Disease Control and Prevention, Honghe, Yunnan, China

and more 1 locations

Home Terms & Conditions Privacy Policy